In human cells infected by HIV type 1 (HIV-1), the viral Gag
protein directs the assembly of nascent viral particles at the plasma
membrane. In murine cells, HIV-1 Gag fails to reach the plasma membrane
and instead forms nonfunctional intracellular aggregates. The viral
determinants of this species incompatibility are previously undefined.
To address this problem, we replaced a region of HIV-1 Gag known to
direct its localization, the matrix (MA) domain, with functionally
homologous regions from Moloney murine leukemia virus (MLV), a murine
retrovirus. An HIV-1 clone carrying such a chimeric Gag protein,
designated murine HIV (MHIV), assembled more efficiently than
nonchimeric HIV-1 and restored plasma membrane localization of Gag in
murine cells. Increased efficiency of viral assembly in murine cells
was observed from MHIV constructs carrying MLV MA in place of HIV-1 MA.
Efficient processing of the HIV-1 capsid protein from the chimeric Gag
polyprotein and subsequent infectivity of MHIV required the presence of
MLV p12 in addition to MLV MA. These findings strongly suggest that the
HIV-1 MA domain of HIV-1 Gag is responsible for the assembly defect in
mouse cells. Although these MHIV do not recruit native HIV-1 Env
efficiently, they are capable of single-round infection when produced
by high-efficiency transfection of human 293 cells and provided with an
HIV-1 Env lacking its cytoplasmic tail. With further adaptation, this
chimeric MHIV approach may provide the basis for creating an infectious
mouse model for HIV/AIDS.